Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:2292:105-113.
doi: 10.1007/978-1-0716-1354-2_9.

PCA3 in Prostate Cancer

Roberta Gunelli  1 , Eugenia Fragalà  1 , Massimo Fiori  2
Affiliations

PCA3 in Prostate Cancer

Roberta Gunelli et al. Methods Mol Biol. 2021.

Abstract

Prostate cancer antigen 3 (PCA3) is a urinary biomarker for prostate cancer and has demonstrated a good specificity and sensitivity representing a minimally invasive test.PCA3 assay could be useful in combination with PSA to suggest an eventual rebiopsy in men who have had one or more previous negative prostate biopsies.Combination of multiple tumor biomarkers will be the trend in the near future to achieve the goal of evaluate the aggressiveness of cancer and at the same time reducing the number of unnecessary biopsies.

Keywords: Biomarker; DD3; PCA3; Prostate Biopsy; Prostate Cancer.

PubMed Disclaimer

References

    1. Bussemakers MJ, van Bokhoven A, Verhaegh GW et al (1999) DD3 a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59:5975–5979 - PubMed
    1. Hessels D, Klein Gunnewiek JMT, van Oort I et al (2003) DD3-PCA3 based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 44:8–16 - DOI
    1. Verhaegh GW, van Bokhoven A, Smit F, Schalken JA, Bussemakers MJ (2000) Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene. J Biol Chem 275:37496–37503 - DOI
    1. Clarke RA, Zhao Z, Guo AY et al (2009) New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression. PLoS One 4(3):e4995. https://doi.org/10.1371/journal.pone.0004995 - DOI - PubMed - PMC
    1. Salagierski M, Verhaegh GW, Jannink SA, Smit FP, Hessel D, Shalken JA (2010) Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate. Prostate 70:70–78 - DOI

LinkOut - more resources